Is creatine phosphokinase (CPK) elevation associated with cannabis hyperemesis syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

CPK Elevation in Cannabis Hyperemesis Syndrome

Creatine phosphokinase (CPK) elevation is not a typical or recognized feature of cannabis hyperemesis syndrome (CHS), but rhabdomyolysis with CPK elevation can occur as a secondary complication when patients engage in extreme compensatory behaviors to alleviate their symptoms.

Direct Association Between CPK and CHS

  • CHS itself does not directly cause CPK elevation. The core pathophysiology involves CB1 receptor activation in the dorsal vagal complex and gut, leading to cyclic vomiting, nausea, and abdominal pain—not primary muscle injury. 1

  • The diagnostic criteria for CHS focus on stereotypical episodic vomiting (≥3 episodes annually), chronic cannabis use (>1 year duration, >4 times weekly), and compulsive hot water bathing (reported in 71% of cases)—none of which include CPK elevation as a diagnostic feature. 1, 2

Indirect CPK Elevation Through Compensatory Behaviors

  • Rhabdomyolysis with CPK elevation has been documented in at least one case report where a patient with CHS discovered that prolonged, extreme exercise (15 hours of continuous jogging) alleviated his symptoms, leading to exercise-induced muscle breakdown. 3

  • This case represents a rare complication of learned compensatory behavior, similar to the more common hot water bathing pattern, rather than a direct manifestation of CHS. 3

  • The mechanism proposed is redistribution of enteric blood flow during extreme physical activity, which may temporarily relieve gastrointestinal symptoms but causes muscle injury. 3

Clinical Implications and Pitfalls

  • When evaluating patients with suspected CHS who present with elevated CPK, clinicians must distinguish between:

    • Primary rhabdomyolysis from other causes (medications, infections, trauma)
    • Secondary rhabdomyolysis from extreme compensatory behaviors (prolonged exercise, excessive bathing in very hot water)
    • Dehydration-related complications from severe vomiting episodes 3, 4

  • Severe dehydration and electrolyte imbalances during the hyperemetic phase of CHS can theoretically contribute to muscle injury, though this is not well-documented in the literature. 4

  • The emergency department evaluation must exclude life-threatening conditions such as acute abdomen, bowel obstruction, mesenteric ischemia, pancreatitis, and myocardial infarction before attributing symptoms solely to CHS—and elevated CPK should prompt consideration of these alternative diagnoses. 1, 2

Management Considerations When CPK is Elevated

  • If rhabdomyolysis is confirmed (CPK typically >1,000 U/L, often >5,000 U/L), aggressive IV fluid resuscitation takes priority to prevent acute kidney injury, alongside standard CHS management. 3

  • Standard acute CHS management includes topical 0.1% capsaicin cream to the abdomen and haloperidol as the preferred dopamine antagonist, with complete avoidance of opioids. 2

  • Counsel patients explicitly about the risks of extreme compensatory behaviors (prolonged hot bathing, excessive exercise) and educate them that these activities, while providing temporary relief, can cause serious complications. 3

  • Long-term management remains complete cannabis cessation for at least 6 months, combined with amitriptyline 75-100 mg at bedtime (starting at 25 mg and titrating weekly) and structured cessation counseling. 2

References

2
Guideline

Acute and Long-Term Management of Cannabinoid Hyperemesis Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

4
Research

Cannabis Hyperemesis Syndrome in Youth: Clinical Insights and Public Health Implications.

International journal of environmental research and public health, 2025

Related Questions

In a patient with cannabinoid hyperemesis syndrome who has experienced ten episodes of vomiting, should she receive a proton pump inhibitor (pantoprazole) or any gastrointestinal prophylaxis?
How should capsaicin cream be applied, and what are the contraindications and precautions?
What are the recommended dosing and usage guidelines for capsaicin cream for pain management?
What is cannabinoid hyperemesis syndrome, including its clinical presentation and recommended management?
Can vomiting and diarrhea be side effects of marijuana use?
In patients with age‑related macular degeneration, does light therapy prevent disease progression and maintain baseline visual function?
What is the typical size of alveoli in the human lung?
What can be added to meloxicam and methocarbamol for rotator cuff tear pain while awaiting further evaluation and surgery?
What is the appropriate management for a 58-year-old man with end-stage osteoarthritis of the right glenohumeral joint and shoulder pain who requests a mattress topper and a bed wedge, given he does not meet the Centurion guideline criteria for these devices?
How should I interpret the serum concentrations of risperidone (22.3 ng/mL), 9‑hydroxy‑risperidone (23.1 ng/mL) and the total active‑moiety level (45.4 ng/mL)?
What laboratory tests should be performed on pericardial fluid to assess for infectious, malignant, and inflammatory etiologies?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.